硝普钠、多巴胺、低分子肝素钙治疗肺源性心脏病顽固性心功能衰竭的临床研究

目的总结硝普钠、多巴胺、低分子肝素钙治疗肺源性心脏病(肺心病)顽固性心功能衰竭的临床效果。方法回顾性分析患者在原有治疗肺心病的基础上使用硝普钠、多巴胺、低分子肝素钙前后临床症状的变化、心功能改善情况及血压、心率、呼吸、24 h尿量改变的情况。结果经硝普钠、多巴胺、低分子肝素钙治疗后,肺心病顽固性心功能衰竭疗效显著(P<0.05),且患者血压、心率、呼吸频率及24 h尿量均明显改善(P<0.05)。结论硝普钠、多巴胺、低分子肝素钙对治疗肺心病顽固性心功能衰竭疗效确切,值得临床推广。

The Clinical Research of Sodium Nitroprusside,Dopamine Combined with Low Molecular Weight Heparin Treating Intractable Heart Failure of Pulmonary Heart Disease

Objective To study the effect of sodium nitroprusside,dopamine combined with low molecular weight heparin treating intractable heart failure of pulmonary heart disease.Methods The clinical of clinincal symptoms,cardiac function improvement and blood pressure,heart rate,breathing,24 h urine volume after the use of sodium nitroprusside,dopamine,low molecular weight heparin on the basis of pulmonary heart disease treatment were retrospectively analyzed.Results Sodium nitroprusside,dopamine,low molecular weight heparin calcium had significant effect on the intractable heart failure of pulmonary heart disease(P <0.05);blood pressure,heart rate,respiratory rate and 24 h urine volume were significantly improved(P <0.05).Conclusion Sodium nitroprusside,dopamine combined with low molecular weight heparin treating intractable heart failure of pulmonary heart disease is of affirmative effect,which is worthy of clinical promotion.